SCHEMBL8555508

SCHEMBL8555508

CCCCCCCON=CC(=O)N(c1ccc2c(c1)C(C)(C)CCC2(C)C)c1ccccc1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
RXRA P19793 16/20 0.43
HNF4A P41235 1/20 0.43
RXRB P28702 12/20 0.41
RXRG P48443 12/20 0.41
PPARG P37231 1/20 0.39
NR1H3 Q13133 1/20 0.39
PTPN11 Q06124 2/20 0.38
PTPN1 P18031 1/20 0.35
PLK1 P53350 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8557645 1.00 RXRA (0.43) RXRAHNF4ARXRBRXRGPPARG
SCHEMBL8555449 1.00 RXRA (0.43) RXRAHNF4ARXRBRXRGPPARG
SCHEMBL8556430 1.00 RXRA (0.43) RXRAHNF4ARXRBRXRGPPARG
SCHEMBL8555716 0.93 RXRA (0.44) RXRAHNF4ARXRBRXRGPTPN1
SCHEMBL8353225 0.87 RXRA (0.39) RXRAHNF4ARXRBRXRGPPARG
SCHEMBL8349950 0.87 RXRA (0.39) RXRAHNF4ARXRBRXRGPPARG
SCHEMBL8352422 0.87 RXRA (0.39) RXRAHNF4ARXRBRXRGPPARG
SCHEMBL8350408 0.87 RXRA (0.39) RXRAHNF4ARXRBRXRGPPARG
SCHEMBL8353210 0.87 RXRA (0.45) RXRARXRBRXRGPTPN1
SCHEMBL8347375 0.86 RXRA (0.40) RXRAHNF4ARXRBRXRGPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5709867-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-01-20 US claimed
US-5709867-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-01-20 US disclosed